North America Breast Cancer Screening Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers North America Breast Cancer Diagnosis Test and the market is Segmented by Test (Genomic Tests and Imaging Tests) and Geography (United States, Canada, and Mexico). The market provides the value (in USD million) for the above-mentioned segments.

North America Breast Cancer Screening Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

North America Breast Cancer Screening Tests Industry Overview

The North American breast cancer screening tests market is fragmented in nature due to the presence of several companies operating regionally. The competitive landscape includes an analysis of companies, including Agendia BV, Fujifilm Holdings Corporation, Hologic Inc., Metabolomic Technologies Inc., Myriad Genetics, QIAGEN NV, Quest Diagnostics Incorporated, and Siemens Healthineers, among others.

North America Breast Cancer Screening Tests Market Leaders

  1. Allengers Medical Systems Limited

  2. Myriad Genetics

  3. Siemens Healthineers

  4. Hologic Inc.

  5. GENERAL ELECTRIC COMPANY

  6. *Disclaimer: Major Players sorted in no particular order
North America Breast Cancer Screening Tests Market Concentration

North America Breast Cancer Screening Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?